Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain ...

Symbicort (budenoside and formoterol) is a combination inhaler used for asthma and COPD. Learn about its uses, side effects, and drug interactions.

Symbicort (budesonide and formoterol) is a combination drug containing an inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) indicated for the treatment of asthma in patients aged six ...

Viatris has launched Breyna, the first U.S.-approved generic version of Symbicort, for patients with chronic obstructive pulmonary disease.

Breyna (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of Symbicort, is now available.

Breyna is indicated for patients with asthma six years of age and as maintenance therapy for people with COPD. Viatris and Kindeva Drug Delivery have launched Breyna (budesonide and formoterol ...

Milton Boyer, CEO of Kindeva Drug Delivery, added: "The launch of Breyna represents a significant milestone as it is the first FDA-approved generic version of Symbicort in the U.S., one of the ...